Copyright
©The Author(s) 2024.
World J Clin Cases. Jan 16, 2024; 12(2): 314-321
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.314
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.314
Table 1 Characteristics of the participants in terms of their demographics and health
Variables | Control group (n = 38) | Intervention group (n = 41) | P value |
Gender | |||
Male/female | 21/17 | 26/15 | 0.46 |
Age (yr) | 50.07 ± 5.88 | 51.04 ± 6.16 | 0.47 |
Body mass index (kg/m2) | 24.8 ± 2.77 | 25.12 ± 3.97 | 0.76 |
Education level | |||
Primary school and below | 13 | 15 | 0.88 |
Junior and senior high school | 20 | 19 | |
College degree or above | 8 | 7 | |
Smoking | |||
Yes | 28 | 31 | 0.84 |
No | 10 | 10 | |
Alcohol drinking | |||
Yes | 20 | 26 | 0.33 |
No | 18 | 15 |
Table 2 Comparison of cardiac and pulmonary functions
Variables | Control group (n = 38) | Intervention group (n = 41) | P value |
LVEF (%) | |||
Before | 46.21 ± 4.72 | 47.01 ± 6.23 | 0.52 |
After | 50.05 ± 5.80 | 57.61 ± 7.42 | < 0.001 |
P value | 0.001 | < 0.001 | |
FVC (L) | |||
Before | 3.53 ± 0.97 | 3.63 ± 1.16 | 0.68 |
After | 3.65 ± 1.01 | 3.99 ± 1.18 | 0.17 |
P value | 0.59 | 0.16 |
Table 3 Comparison of exercise endurance
Variables | Control group (n = 38) | Intervention group (n = 41) | P value |
6MWT (m) | |||
Before | 219.90 ± 34.67 | 216.53 ± 24.25 | 0.61 |
After | 232.18 ± 33.12 | 256.98 ± 32.00 | 0.001 |
P value | 0.10 | < 0.001 | |
VO2 [mL/(kg·min)] | |||
Before | 11.23 ± 3.47 | 11.65 ± 4.30 | 0.63 |
After | 15.72 ± 4.98 | 20.16 ± 5.06 | < 0.001 |
P value | < 0.001 | < 0.001 |
Table 4 Comparison between groups of patients in terms of Seattle Angina Questionnaire and medication compliance
Variables | Control group (n = 38) | Intervention group (n = 41) | P value |
SAQ-PL | |||
Before | 59.89 ± 8.68 | 60.11 ± 11.16 | 0.92 |
After | 62.29 ± 9.73 | 72.46 ± 10.51 | < 0.001 |
P value | 0.26 | < 0.001 | |
SAQ-AS | |||
Before | 53.25 ± 8.03 | 54.09 ± 10.66 | 0.69 |
After | 59.71 ± 7.68 | 70.13 ± 11.19 | < 0.001 |
P value | < 0.001 | < 0.001 | |
SAQ-AF | |||
Before | 66.78 ± 6.29 | 65.74 ± 7.80 | 0.51 |
After | 79.87 ± 4.65 | 84.52 ± 9.91 | 0.01 |
P value | < 0.001 | < 0.001 | |
SAQ-TS | |||
Before | 74.91 ± 7.75 | 76.57 ± 8.02 | 0.35 |
After | 80.08 ± 9.20 | 87.91 ± 9.96 | < 0.001 |
P value | 0.009 | < 0.001 | |
SAQ-DP | |||
Before | 68.22 ± 7.54 | 68.26 ± 8.27 | 0.98 |
After | 75.17 ± 6.18 | 82.02 ± 6.01 | < 0.001 |
P value | < 0.001 | < 0.001 | |
Medication compliance | 7.42 ± 1.96 | 9.46 ± 2.99 | < 0.001 |
- Citation: Gao T, Luo JL, Guo P, Hu XW, Wei XY, Hu Y. Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease. World J Clin Cases 2024; 12(2): 314-321
- URL: https://www.wjgnet.com/2307-8960/full/v12/i2/314.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i2.314